By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Drug store chain Kerr Drug and the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill plan to investigate the feasibility of implementing a pharmacogenomic program at the community pharmacy level directed at Plavix (clopidogrel).

Under the six-month study announced today, the partners will jointly develop a protocol, evaluate physician and patients opinions, and research reimbursement challenges and regulatory requirements to such a program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.